Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice

Overview of attention for article published in Vascular Health and Risk Management, August 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 35 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

GENOTYPE- OR PHENOTYPE-BASED DRUG FORMULATION

Application WO-2013178565-A1

World Intellectual Property Organisation (WIPO)

Genotype and phenotype-based medicinal formulations

Application EP-2668945-A1

European Patent Office